학술논문

Short-Term Risk of Endocrinopathies Following Immune Checkpoint Inhibition for Non-Small Cell Lung Cancer.
Document Type
Article
Source
Connecticut Medicine; Nov/Dec2019, Vol. 83 Issue 10, p503-508, 6p
Subject
NON-small-cell lung carcinoma
PEMBROLIZUMAB
GLUTAMATE decarboxylase
THYROTROPIN receptors
THYROID diseases
THYROTROPIN
ISLANDS of Langerhans
Language
ISSN
00106178
Abstract
Copyright of Connecticut Medicine is the property of Connecticut State Medical Society and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)